VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model

Anticancer Research

Volumn 33, Issue 2, 2013, Pages 409-418

  Shi, Yuzhen ^a,b   Tong, Mingmin ^c   Wu, Yuefei ^a   Yang, Zhijian ^d   Hoffman, Robert M ^g,h   Zhang, Yong ^g   Tian, Ying ^e   Qi, Mingmei ^f   Lin, Yanfei ^a   Liu, Yongkang ^a   Dai, Lingling ^a   Sun, Yu ^d   Wang, Zhongqiu ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SUZHOU MUNICIPAL HOSPITAL   (China)

^d Origin Bioscience Inc   (China)

^e NANJING UNIVERSITY   (China)

^f CHONGQING MEDICAL UNIVERSITY   (China)

^g ANTICANCER INC   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

GFP; Nude mice; Orthotopic; Pancreatic cancer; ShRNA; VEGF C

Indexed keywords

CD31 ANTIGEN; GEMCITABINE; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY D2-40; SHORT HAIRPIN RNA; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MICROVESSEL DENSITY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR C; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875892819     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fu X, Guadagni F and Hoffman RM: A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 89: 5645-5649, 1992.
2. Furukawa T, Kubota T, Watanabe M, Kitajima M and Hoffman RM: A novel 'patient-like' treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 53: 3070-3072, 1993.
3. Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR and Hoffman RM: Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62: 1534-1540, 2002.
4. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM and Bouvet M: A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113: 151-160, 2003.
5. Tran Cao HS, Bouvet M, Kaushal S, Keleman A, Romney E, Kim G, Fruehauf J, Imagawa DK, Hoffman RM and Katz MH: Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther 9: 2068-2078, 2010.
6. Achen MG, Mann GB and Stacker SA: Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 94: 1355-1360, 2006.
7. Schneider M, Buchler P, Giese N, Giese T, Wilting J, Buchler MW and Friess H: Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. Int J Oncol 28: 883-890, 2006.
8. Huang C, Huang R, Chang W, Jiang T, Huang K, Cao J, Sun X and Qiu Z: The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. Neoplasma 59: 52-61, 2012.
9. Li K, Li MJ, He T, Zheng Z, Zheng XL, Qu BH, Wang Y, Duan X and Zheng YJ: Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis. Zhonghua Yi Xue Za Zhi 89: 2386-2390, 2009.
10. Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y and Manabe T: Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Pancreas 34: 444-451, 2007.
11. He Y, Karpanen T and Alitalo K: Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 1654: 3-12, 2004.
12. Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE and Singh RK: Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65: 9004-9011, 2005.
13. Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B and Skobe M: Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66: 2650-2657, 2006.
14. Chaudary N, Milosevic M and Hill RP: Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecol Oncol 123: 393-400, 2011.
15. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M and Alitalo K: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61: 1786-1790, 2001.
16. Brummelkamp TR, Bernards R and Agami R: Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247, 2002.
17. Xia H, Mao Q, Paulson HL and Davidson BL: siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20: 1006-1010, 2002.
18. Qin XF, An DS, Chen IS and Baltimore D: Inhibiting HIV-1 infection in human T-cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 100: 183-188, 2003.
19. Nishitsuji H, Ikeda T, Miyoshi H, Ohashi T, Kannagi M and Masuda T: Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes Infect 6: 76-85, 2004.
20. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19, 1995.
21. Li K, Tao J, Li T, Yu Z, Yang Z, Wu H, Xiong J and Wang C: Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer. J Huazhong Univ Sci Technolog Med Sci 27: 51-53, 2007.
22. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T and Alitalo K: Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825, 2002.
23. Hoffman RM and Yang M: Subcellular imaging in the live mouse. Nat Protoc 1: 775-782, 2006.
24. Hoffman RM and Yang M: Color-coded fluorescence imaging of tumor-host interactions. Nat Protoc 1: 928-935, 2006.
25. Hoffman RM and Yang M: Whole-body imaging with fluorescent proteins. Nat Protoc 1: 1429-1438, 2006.